Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
- PMID: 29535852
- PMCID: PMC5844041
- DOI: 10.1080/20018525.2018.1440868
Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults
Abstract
Although a minority of asthma patients suffer from severe asthma, they represent a major clinical challenge in terms of poor symptom control despite high-dose treatment, risk of exacerbations, and side effects. Novel biological treatments may benefit patients with severe asthma, but are expensive, and are only effective in appropriately targeted patients. In some patients, symptoms are driven by other factors than asthma, and all patients with suspected severe asthma ('difficult asthma') should undergo systematic assessment, in order to differentiate between true severe asthma, and 'difficult-to-treat' patients, in whom poor control is related to factors such as poor adherence or co-morbidities. The Nordic Consensus Statement on severe asthma was developed by the Nordic Severe Asthma Network, consisting of members from Norway, Sweden, Finland, Denmark, Iceland and Estonia, including representatives from the respective national respiratory scientific societies with the aim to provide an overview and recommendations regarding the diagnosis, systematic assessment and management of severe asthma. Furthermore, the Consensus Statement proposes recommendations for the organization of severe asthma management in primary, secondary, and tertiary care.
Keywords: Asthma; co-morbidities; diagnosis; guideline; management; prevalence; severe.
Conflict of interest statement
No potential conflict of interest was reported by the authors.
Figures
Similar articles
-
Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort.ERJ Open Res. 2023 Apr 3;9(2):00687-2022. doi: 10.1183/23120541.00687-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37020835 Free PMC article.
-
Nordic consensus report on asthma management. Nordic Asthma Consensus Group.Respir Med. 2000 Apr;94(4):299-327. doi: 10.1053/rmed.1999.0702. Respir Med. 2000. PMID: 10845429
-
Differentiation of adult severe asthma from difficult-to-treat asthma - Outcomes of a systematic assessment protocol.Respir Med. 2018 Dec;145:41-47. doi: 10.1016/j.rmed.2018.10.020. Epub 2018 Oct 22. Respir Med. 2018. PMID: 30509715
-
Consensus document on the diagnosis of severe uncontrolled asthma.J Investig Allergol Clin Immunol. 2012;22(7):460-75; quiz 2 p following 475. J Investig Allergol Clin Immunol. 2012. PMID: 23397668
-
Co-morbidities in severe asthma: Clinical impact and management.Respirology. 2017 May;22(4):651-661. doi: 10.1111/resp.13026. Epub 2017 Mar 22. Respirology. 2017. PMID: 28328160 Review.
Cited by
-
Body mass index increase: a risk factor for forced expiratory volume in 1 s decline for overweight and obese adults with asthma.ERJ Open Res. 2022 Oct 24;8(4):00110-2022. doi: 10.1183/23120541.00110-2022. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36299358 Free PMC article.
-
Efficacy, adverse events, and inter-drug comparison of mepolizumab and reslizumab anti-IL-5 treatments of severe asthma - a systematic review and meta-analysis.Eur Clin Respir J. 2018 Nov 7;5(1):1536097. doi: 10.1080/20018525.2018.1536097. eCollection 2018. Eur Clin Respir J. 2018. PMID: 30533206 Free PMC article. Review.
-
Monoclonal Antibodies and Airway Diseases.Int J Mol Sci. 2020 Dec 13;21(24):9477. doi: 10.3390/ijms21249477. Int J Mol Sci. 2020. PMID: 33322143 Free PMC article. Review.
-
Patient perspectives on living with severe asthma in Denmark and Sweden.Eur Clin Respir J. 2020 Dec 16;8(1):1856024. doi: 10.1080/20018525.2020.1856024. Eur Clin Respir J. 2020. PMID: 33414901 Free PMC article.
-
The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children.Ann Thorac Med. 2021 Jan-Mar;16(1):4-56. doi: 10.4103/atm.ATM_697_20. Epub 2021 Jan 14. Ann Thorac Med. 2021. PMID: 33680125 Free PMC article.
References
-
- Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43:343–20. - PubMed
-
- Zeiger RS, Schatz M, Dalal AA, et al. Utilization and costs of severe uncontrolled asthma in a managed-care setting. J Allergy Clin Immunol Pract. 2016;4:120–129.e3. - PubMed
-
- Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax. 2011;66:910–917. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources